Controversies in Adjuvant Therapy for Pancreatic Cancer. Parag Sanghvi M.D. Tasha McDonald M.D. Department of Radiation Medicine OHSU. Median Survival of Patients With Pancreatic Cancer. Localized/ Resectable 15-19 months 10% Locally Advanced 6-10 months 30%
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Parag Sanghvi M.D.
Tasha McDonald M.D.
Department of Radiation Medicine